8928 related articles for article (PubMed ID: 1371338)
1. Loss of c-kit expression in cultured melanoma cells.
Lassam N; Bickford S
Oncogene; 1992 Jan; 7(1):51-6. PubMed ID: 1371338
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma.
Loganzo F; Dosik JS; Zhao Y; Vidal MJ; Nanus DM; Sudol M; Albino AP
Oncogene; 1993 Oct; 8(10):2637-44. PubMed ID: 7690926
[TBL] [Abstract][Full Text] [Related]
3. KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells.
Zakut R; Perlis R; Eliyahu S; Yarden Y; Givol D; Lyman SD; Halaban R
Oncogene; 1993 Aug; 8(8):2221-9. PubMed ID: 7687762
[TBL] [Abstract][Full Text] [Related]
4. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
[TBL] [Abstract][Full Text] [Related]
5. Expression of c-kit receptor in normal and transformed human nonlymphoid tissues.
Natali PG; Nicotra MR; Sures I; Santoro E; Bigotti A; Ullrich A
Cancer Res; 1992 Nov; 52(22):6139-43. PubMed ID: 1384954
[TBL] [Abstract][Full Text] [Related]
6. Gene expression in melanoma cell lines and cultured melanocytes: correlation between levels of c-src-1, c-myc and p53.
Chenevix-Trench G; Martin NG; Ellem KA
Oncogene; 1990 Aug; 5(8):1187-93. PubMed ID: 1697409
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of erythroid differentiation by stem cell factor in K562 cells expressing the c-kit gene.
Ogawa K; Tashima M; Toi T; Sawai H; Sawada H; Fujita J; Maruyama Y; Okuma M
Exp Hematol; 1994 Jan; 22(1):45-51. PubMed ID: 7506674
[TBL] [Abstract][Full Text] [Related]
8. c-kit mRNA expression in human and murine hematopoietic cell lines.
André C; d'Auriol L; Lacombe C; Gisselbrecht S; Galibert F
Oncogene; 1989 Aug; 4(8):1047-9. PubMed ID: 2474787
[TBL] [Abstract][Full Text] [Related]
9. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.
Montone KT; van Belle P; Elenitsas R; Elder DE
Mod Pathol; 1997 Sep; 10(9):939-44. PubMed ID: 9310959
[TBL] [Abstract][Full Text] [Related]
10. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M
Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075
[TBL] [Abstract][Full Text] [Related]
11. Phorbol ester 12-O-tetradecanoylphorbol-13-acetate down-regulates expression of the c-kit proto-oncogene product.
Asano Y; Brach MA; Ahlers A; de Vos S; Butterfield JH; Ashman LK; Valent P; Gruss HJ; Herrmann F
J Immunol; 1993 Sep; 151(5):2345-54. PubMed ID: 7689605
[TBL] [Abstract][Full Text] [Related]
12. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
13. Steel and c-kit in the development of avian melanocytes: a study of normally pigmented birds and of the hyperpigmented mutant silky fowl.
Lecoin L; Lahav R; Martin FH; Teillet MA; Le Douarin NM
Dev Dyn; 1995 May; 203(1):106-18. PubMed ID: 7544170
[TBL] [Abstract][Full Text] [Related]
14. Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications.
Welker P; Schadendorf D; Artuc M; Grabbe J; Henz BM
Br J Cancer; 2000 Apr; 82(8):1453-8. PubMed ID: 10780526
[TBL] [Abstract][Full Text] [Related]
15. The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression.
Eisen T; Easty DJ; Bennett DC; Goding CR
Oncogene; 1995 Nov; 11(10):2157-64. PubMed ID: 7478537
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of the protein tyrosine kinase c-Yes but not c-Src by neurotrophins in human brain-metastatic melanoma cells.
Marchetti D; Parikh N; Sudol M; Gallick GE
Oncogene; 1998 Jun; 16(25):3253-60. PubMed ID: 9681823
[TBL] [Abstract][Full Text] [Related]
17. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
[TBL] [Abstract][Full Text] [Related]
18. The expression of the c-kit receptor by epidermal melanocytes may be reduced in vitiligo.
Norris A; Todd C; Graham A; Quinn AG; Thody AJ
Br J Dermatol; 1996 Feb; 134(2):299-306. PubMed ID: 8746346
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of the c-kit and stem cell factor genes in breast carcinomas.
Hines SJ; Organ C; Kornstein MJ; Krystal GW
Cell Growth Differ; 1995 Jun; 6(6):769-79. PubMed ID: 7545433
[TBL] [Abstract][Full Text] [Related]
20. met and HGF-SF in normal melanocytes and melanoma cells.
Halaban R; Rubin JS; White W
EXS; 1993; 65():329-39. PubMed ID: 8380740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
